Antiparasitics In The Animal Health Industry: 2007 Edition

• Assess the most significant parasites affecting companion and food producing animals, and the impact they have on their host.
• Examine the methods used to treat or control the parasites with all major product categories discussed in detail including mode of action and spectrum of activity.
• Analyse company profiles for both originator companies with major interests in the sector as well as generic manufacturers to help you identify competitors.
• Identify the size and structure of the world market, its recent developments and future growth prospects to help you plan your future strategy.

• The ultimate guide to the animal health industry and its major players is updated and improved for 2007. With 26 company profiles included to further enhance your competitor intelligence
• In-depth company profiles are given for the top 12 animal health companies and a further 14 second tier companies.

• The continuous growth of the whole segment in recent years has mostly been due to the new products commercialised in the companion animal ectoparasiticides segment.
• However, sales in other parts of the market have been affected by growing generic penetration.
• The development of vaccines against parasites is still a subject of high interest in both the academic and commercial sectors. However outside the coccidiosis sector these have generated fairly modest revenues to date.
• The major players in the sector are working on the development of novel antiparasitics, and some new products are expected to reach the market in the next 5 years.

• Major Livestock and Companion Animal Parasites
• Antiparasitic Products
• The Market for Antiparasitic Products
• Company Profiles - for originator companies and generic manufacturers

CHAPTER 1 MAJOR LIVESTOCK AND COMPANION ANIMAL PARASITES

1.1 Cattle parasites

1.1.1 Endoparasites

Gastrointestinal nematodes

Tapeworms

Lungworms

Liver fluke

Protozoa

Treatment and control of endoparasites

1.1.2 Ectoparasites

Flies

Lice

Mites

Ticks

Treatment and control

1.2 Sheep parasites

1.2.1 Endoparasites

Gastrointestinal nematodes

Tapeworms

Lungworms

Liver flukes

Protozoa

Treatment and control

1.2.2 Ectoparasites

Flies

Mites

Lice

Ticks

Treatment and control

1.3 Pig parasites

1.3.1 Endoparasites

Gastrointestinal nematodes

Protozoa

Treatment and control

1.3.2 Ectoparasites

Treatment and control

1.4 Horse parasites

1.4.1 Endoparasites

Treatment and control

1.4.2 Ectoparasites

Treatment and control

1.5 Small animal parasites

1.5.1 Endoparasites

Gastrointestinal worms

Tapeworms

Heartworm

Protozoa

Treatment and control

1.5.2 Ectoparasites

Fleas

Ticks

Mites

Treatment and control

CHAPTER 2 ANTIPARASITIC PRODUCTS

2.1 Endoparasiticides

2.1.1 Imidazothiazoles

2.1.2 Benzimidazoles

2.1.3 Tetrahydropyrimidines

2.1.4 Macrocyclic lactones

2.1.5 Other endoparasiticides

2.2 Endectocides

2.2.1 Avermectins

Ivermectin

Abamectin

Eprinomectin

Doramectin

Selamectin

Emamectin

2.2.2 Milbemycins

Milbemycin oxime

Moxidectin

2.2.3 Quasi-endectocides

2.3 Ectoparasiticides

2.3.1 Carbamates

2.3.2 Insect growth regulators

Chitin synthesis inhibitors

Juvenile hormone mimics

Other insect growth regulators

2.3.3 Macrocyclic lactones

2.3.4 Nicotinoids

2.3.5 Organophosphates

2.3.6 Pyrazoles

2.3.7 Pyrethrins and synthetic pyrethroids

2.3.8 Spinosyns

2.3.9 Others

2.3.10 Combination products

2.4 Parasite vaccines

2.4.1 Parasitic bronchitis vaccine

2.4.2 Cattle tick vaccine

2.4.3 Giardiasis vaccine

2.4.4 Toxoplasmosis vaccine

2.4.5 Neosporosis vaccine

2.5 Antiparasitic research

2.5.1 Endoparasiticide and endectocide research

2.5.2 Ectoparasiticide research

2.5.3 Parasite vaccine research

2.5.4 Alternative approaches to parasite control

CHAPTER 3 THE MARKET FOR ANTIPARASITIC PRODUCTS

3.1 The world market for animal health products

3.1.1 Structure of the world market by product category

3.2 The world market for antiparasitic products

3.2.1 Antiparasitic product sectors

3.2.2 Company involvement

3.2.3 Leading country markets

3.2.4 Market prospects

3.3 National market profiles

3.3.1 Australia

3.3.1.1 Market size and recent growth

3.3.1.2 Market structure

3.3.1.3 Structure and development of the Australian antiparasitics market

Large animal antiparasitics

Small animal antiparasitics

3.3.1.4 Antiparasitic market prospects

Market forecast

3.3.2 Brazil

3.3.2.1 Market size and recent growth

3.3.2.2 Market structure

3.3.2.3 Structure and development of the Brazilian antiparasitics market

Anthelmintics

Ectoparasiticides

Endectocides

3.3.2.4 Antiparasitic market prospects

Market forecast

3.3.3 France

3.3.3.1 Market size and recent growth

3.3.3.2 Market structure

3.3.3.3 Structure and development of the French antiparasitics market

Anthelmintics

Endectocides

Insecticides/ectoparasiticides

3.3.3.4 Antiparasitic market prospects

Market forecast

3.3.4 Japan

3.3.4.1 Market size and recent growth

3.3.4.2 Market structure

3.3.4.3 Structure and development of the Japanese antiparasitics market

Anthelmintics

Endectocides

Ectoparasiticides

3.3.4.4 Antiparasitic market prospects

Market forecast

3.3.5 UK

3.3.5.1 Market size and recent growth

3.3.5.2 Market structure

3.3.5.3 Structure and development of the UK antiparasitics market

Anthelmintics

Ectoparasiticides

Endectocides

3.3.5.4 Antiparasitic growth prospects

Market forecast

3.3.6 USA

3.3.6.1 Market size and recent growth

3.3.6.2 Market structure

3.3.6.3 Size and structure of the US antiparasitics market

Pet flea/tick treatments

Heartworm preventatives

Cattle wormers

Equine anthelmintics

Others

3.3.6.4 Antiparasitic market prospects

Market forecast

3.3.7 Other significant markets

CHAPTER 4 COMPANY PROFILES

4.1 Leading originator companies

4.1.1 Bayer

4.1.1.1 Company background

4.1.1.2 Antiparasitics business

4.1.1.3 Major antiparasitic products

Imidacloprid

Other ectoparasiticides

Anthelmintics and endectocides

4.1.1.4 Antiparasitic research

4.1.2 Fort Dodge

4.1.2.1 Company background

4.1.2.2 Antiparasitics business

4.1.2.3 Major antiparasitic products

Moxidectin

Other antiparasitics

4.1.2.4 Antiparasitic research

4.1.3 Intervet

4.1.3.1 Company background

4.1.3.2 Antiparasitics business

4.1.3.3 Major antiparasitic products

Fenbendazole

Other anthelmintics and endectocides

Ectoparasiticides

Vaccines

4.1.3.4 Antiparasitic research

4.1.4 Merial

4.1.4.1 Company background

4.1.4.2 Antiparasitics business

4.1.4.3 Major antiparasitic products

Fipronil

Avermectins

Others

4.1.4.4 Antiparasitic research

4.1.5 Novartis

4.1.5.1 Company background

4.1.5.2 Antiparasitics business

4.1.5.3 Major antiparasitic products

Companion animal products

Livestock products

Premise and environmental parasite controls

4.1.5.4 Antiparasitic research

4.1.6 Pfizer

4.1.6.1 Company background

4.1.6.2 Antiparasitics business

4.1.6.3 Major antiparasitic products

Doramectin

Selamectin

Others

4.1.6.4 Antiparasitic research

4.1.7 Schering-Plough

4.1.7.1 Company background

4.1.7.2 Antiparasitics business

4.1.7.3 Major antiparasitic products

Ectoparasiticides

Anthelmintics and endectocides

4.1.7.4 Antiparasitic research

4.2 Major generic companies

4.2.1 Ancare

4.2.1.1 Company background

4.2.1.2 Strategy

4.2.1.3 Product range

4.2.1.4 Recent launches

4.2.2 Farnam

4.2.2.1 Company background

4.2.2.2 Strategy

4.2.2.3 Product range

4.2.3 Norbrook

4.2.3.1 Company background

4.2.3.2 Strategy

4.2.3.3 Product range

4.2.4 Phoenix Scientific

4.2.4.1 Company background

4.2.4.2 Strategy

4.2.4.3 Product range

4.2.5 Virbac

4.2.5.1 Company background

4.2.5.2 Strategy

4.2.5.3 Product range

Endectocides

Others